{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:20:51Z","timestamp":1792167651747,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":495,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.bbmt.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T03:16:42Z","timestamp":1377573402000},"page":"1670-1676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Individual Quality Assessment of Autografting by Probability Estimation for Clinical Endpoints: A Prospective Validation Study from the European Group for Blood and Marrow Transplantation"],"prefix":"10.1016","volume":"19","author":[{"given":"Francesco","family":"Lanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C.","family":"Campioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Walewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangelo","family":"Spedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fiamenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Knopi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Swierkowska-Czeneszew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Petriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Fruehauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapani","family":"Ruuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans E.","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.08.005_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.bmt.1703828","article-title":"Individual quality assessment of autografting by probability evaluation: A model estimated by analysis of graft-related endpoints in 204 patients with malignancies","volume":"31","author":"Baech","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/14653240500499549","article-title":"Quality assessment of autografting by probability evaluation: model estimation by clinical endpoints in newly diagnosed multiple myeloma patients","volume":"8","author":"Roer","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2013.08.005_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbmt.2004.12.329","article-title":"What is quality in a transplant program?","volume":"11","author":"LeMaistre","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/MOH.0b013e328330990f","article-title":"Trends of hematopoietic stem cell transplantation in the third millennium","volume":"16","author":"Gratwohl","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2013.08.005_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry","volume":"5","author":"Sutherland","year":"1996","journal-title":"J\u00a0Hematother"},{"key":"10.1016\/j.bbmt.2013.08.005_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/bmt.2009.7","article-title":"The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies","volume":"43","author":"Gratwohl","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1365-2141.2000.01932.x","article-title":"Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training","volume":"108","author":"Barnett","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.08.005_bib8","first-page":"247","article-title":"Single platform enumeration of viable CD34+ Cells","volume":"17","author":"Keeney","year":"2003","journal-title":"J\u00a0Biol Regulators"},{"issue":"1","key":"10.1016\/j.bbmt.2013.08.005_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/bmt.2011.32","article-title":"Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program","volume":"47","author":"Chabannon","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib10","first-page":"378","article-title":"Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation","volume":"6","author":"Larsson","year":"1998","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bbmt.2013.08.005_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/blood.V85.2.588.588","article-title":"Peripheral blood stem cell transplants for multiple myeloma: Identification of favourable variables for rapid engraftment in 225 patients","volume":"85","author":"Tricot","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.08.005_bib12","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/j.1537-2995.2011.03085.x","volume":"51","author":"Alexander","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.08.005_bib13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.bmt.1702708","article-title":"Predictive factors for long-term engraftment of autologous blood stem cells","volume":"26","author":"Duggan","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib14","unstructured":"Eastern Cooperative Oncology Group. Common Toxicity Criteria. Retrieved from www.ecog.dfci.harvard.edu."},{"key":"10.1016\/j.bbmt.2013.08.005_bib15","first-page":"270","article-title":"Clinical validation\u2014the final step in translational medicine! From CD34 enumeration to probability estimation of autograft quality","volume":"16","author":"Johnsen","year":"2002","journal-title":"J\u00a0Biol Regulators"},{"key":"10.1016\/j.bbmt.2013.08.005_bib16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3324\/haematol.13204","article-title":"Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy","volume":"93","author":"Tricot","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.08.005_bib17","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.08.005_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbmt.2008.07.004","article-title":"Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation","volume":"14","author":"Pusic","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib19","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1182\/blood.V83.12.3787.3787","article-title":"Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma","volume":"83","author":"Haas","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.08.005_bib20","doi-asserted-by":"crossref","unstructured":"Lanza F, Lemoli R, Olivieri A, et\u00a0al. Factors affecting successful mobilization with plerixafor: An Italian prospective survey in 215 patients with multiple myeloma and lymphoma. Transfusion. 2013 Jun 19. doi: 10.1111\/trf.12265.","DOI":"10.1111\/trf.12265"},{"key":"10.1016\/j.bbmt.2013.08.005_bib21","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","article-title":"An analysis of engraftment kinetics as a function of the CD 34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy","volume":"86","author":"Weaver","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.08.005_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14653240701326756","article-title":"Adverse events after infusions of\u00a0cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age","volume":"9","author":"Milone","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2013.08.005_bib23","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","article-title":"Factors that influence collection and engraftment of autologous peripheral-blood stem cells","volume":"13","author":"Besinger","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.08.005_bib24","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/leu.2009.127","article-title":"International Myeloma Working Group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)","volume":"23","author":"Giralt","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.08.005_bib25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.bmt.1705147","article-title":"Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers","volume":"36","author":"Goterris","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib26","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1182\/blood-2009-11-252197","article-title":"Higher incidence of relapse in patients with acute myelocytic leukaemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission","volume":"116","author":"Gorin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.08.005_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/bmt.2011.33","article-title":"Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate risk AML patients treated in first CR by autologous or allogeneic transplantation","volume":"47","author":"Milone","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1705763","article-title":"Patients mobilizing large numbers of CD34+ cells (\u201csuper mobilizers\u201d) have improved survival in autologous stem cell transplantation for lymphoid malignancies","volume":"40","author":"Bolwell","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib29","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbmt.2010.11.021","article-title":"Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"17","author":"Stiff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.08.005_bib30","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/j.1537-2995.2007.01440.x","volume":"47","author":"Bashey","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.08.005_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/1042819031000067585","article-title":"Poor mobilization of peripheral blood stem cells is a risk factors for worse outcome in lymphoma patients undergoing autologous stem cell transplantation","volume":"44","author":"Gordan","year":"2003","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.bbmt.2013.08.005_bib32","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1200\/JCO.2006.06.0673","article-title":"Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia","volume":"24","author":"Kalaycio","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2013.08.005_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ajh.21400","article-title":"Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma","volume":"84","author":"Hosing","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2013.08.005_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cyto.b.20607","article-title":"Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia","volume":"80","author":"Della Porta","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.bbmt.2013.08.005_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bmt.2011.82","article-title":"Proposed definition of \u201cpoor mobilizer\u201d in lymphoma and multiple myeloma: An analytic hierarchy process by ad hoc working group Gruppo Italiano Trapianto di Midollo Osseo","volume":"47","author":"Olivieri","year":"2012","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113003820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113003820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:45:20Z","timestamp":1761057920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113003820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1083879113003820"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.08.005","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individual Quality Assessment of Autografting by Probability Estimation for Clinical Endpoints: A Prospective Validation Study from the European Group for Blood and Marrow Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}